Azoramide: a new drug for the treatment of type 2 diabetes?

被引:3
|
作者
Guillen, Carlos [1 ,2 ]
机构
[1] Univ Complutense Madrid, Fac Pharm, Dept Biochem & Mol Biol 2, E-28040 Madrid, Spain
[2] Inst Salud Carlos III, Spanish Biomed Res Ctr Diabet & Associated Metab, Madrid, Spain
关键词
ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; ER STRESS; LIFE; DEATH; PERK;
D O I
10.21037/atm.2016.10.18
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Alogliptin for the treatment of type 2 diabetes: a drug safety evaluation
    Yabe, Daisuke
    Seino, Yutaka
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (02) : 249 - 264
  • [32] Adherence of people with type 2 diabetes mellitus to drug treatment
    Gomes-Villas Boas, Lilian Cristiane
    Foss-Freitas, Maria Cristina
    Pace, Ana Emilia
    REVISTA BRASILEIRA DE ENFERMAGEM, 2014, 67 (02) : 268 - 273
  • [33] Novel approaches to drug discovery for the treatment of type 2 diabetes
    Xu, Xing
    Wang, Gaihong
    Zhou, Tingting
    Chen, Lili
    Chen, Jing
    Shen, Xu
    EXPERT OPINION ON DRUG DISCOVERY, 2014, 9 (09) : 1047 - 1058
  • [34] Drug Treatment for Type 2 Diabetes Modifies Fibroid Risk
    Edwards, Digna R. Velez
    Hartmann, Katherine E.
    Shah, Anushi
    Xu, Hua
    Edwards, Todd L.
    JOURNAL OF WOMENS HEALTH, 2013, 22 (10) : 905 - 906
  • [35] Type 2 diabetes healthcare costs and drug treatment patterns
    Erwin, G
    Rajagopalan, R
    Taylor, B
    Wilson, P
    Schaneman, J
    Kleinman, N
    DIABETES, 2004, 53 : A282 - A282
  • [36] Drug evaluation: Tagatose in the treatment of type 2 diabetes and obesity
    Moore, Mary Courtney
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (10) : 924 - 935
  • [37] Pharmacokinetic drug evaluation of exenatide for the treatment of type 2 diabetes
    Molina Vega, Maria
    Araceli, Munoz-Garach
    Tinahones, Francisco J.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (02) : 207 - 217
  • [38] Selecting the right drug treatment for adults with type 2 diabetes
    Montori, Victor M.
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 352
  • [39] New drug targets for type 2 diabetes and the metabolic syndrome
    David E. Moller
    Nature, 2001, 414 : 821 - 827
  • [40] New drug targets for type 2 diabetes and the metabolic syndrome
    Moller, DE
    NATURE, 2001, 414 (6865) : 821 - 827